☰

Morgane Thomsen - Publications

Affiliations: 
2006-2016 Harvard Medical School / McLean Hospital 
 2016- Psychiatric Center Copenhagen 
 2020- Department of Neuroscience University of Copenhagen, København, Denmark 
Area:
Addiction
Tree Info Grants Similar researchers PubMed Report error

55/56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Díaz-Megido C, Thomsen M. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice. Psychopharmacology. 240: 1287-1298. PMID 37106129 DOI: 10.1007/s00213-023-06367-x  0.309
2023 Tonetto S, Weikop P, Brudek T, Thomsen M. Behavioral and biochemical effects of alcohol withdrawal in female C3H/HeNRj and C57BL/6JRj mice. Frontiers in Behavioral Neuroscience. 17: 1143720. PMID 36910126 DOI: 10.3389/fnbeh.2023.1143720  0.745
2022 Allingbjerg ML, Hansen SN, Secher A, Thomsen M. Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice. Experimental and Clinical Psychopharmacology. PMID 36480394 DOI: 10.1037/pha0000620  0.38
2022 Thomsen M, Crittenden JR, Lindsley CW, Graybiel AM. Effects of acute and repeated administration of the selective M PAM VU0152099 on cocaine versus food choice in male rats. Addiction Biology. 27: e13145. PMID 35229940 DOI: 10.1111/adb.13145  0.664
2021 Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A. The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. British Journal of Pharmacology. PMID 34532853 DOI: 10.1111/bph.15677  0.623
2021 Crittenden JR, Zhai S, Sauvage M, Kitsukawa T, Burguière E, Thomsen M, Zhang H, Costa C, Martella G, Ghiglieri V, Picconi B, Pescatore KA, Unterwald EM, Jackson WS, Housman DE, et al. CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors. Neurobiology of Disease. 105473. PMID 34371144 DOI: 10.1016/j.nbd.2021.105473  0.596
2021 Bornebusch AB, Mason GF, Tonetto S, Damsgaard J, Gjedde A, Fink-Jensen A, Thomsen M. Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice. Psychopharmacology. PMID 33410985 DOI: 10.1007/s00213-020-05735-1  0.743
2020 Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, et al. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent. Neurochemistry International. 104772. PMID 32464226 DOI: 10.1016/J.Neuint.2020.104772  0.618
2020 Weikop P, Jensen KL, Thomsen M. Effects of muscarinic M receptor stimulation on reinforcing and neurochemical effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32344426 DOI: 10.1038/S41386-020-0684-1  0.777
2020 Justinussen J, Dall C, Dencker D, Gjedde A, Fink-Jensen A, Thomsen M. Revealing a compulsive phenotype in cholinergic M mice depends on the inter-trial interval initiation settings in a five choice serial reaction time task. Behavioural Brain Research. 112649. PMID 32344038 DOI: 10.1016/J.Bbr.2020.112649  0.768
2019 Thomsen M, Holst JJ, Molander A, Linnet K, Ptito M, Fink-Jensen A. Correction to: Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Psychopharmacology. PMID 31768561 DOI: 10.1007/S00213-019-05374-1  0.609
2019 Penrod RD, Thomsen M, Taniguchi M, Guo Y, Cowan CW, Smith LN. The activity-regulated cytoskeleton-associated protein, Arc/Arg3.1, influences mouse cocaine self-administration. Pharmacology, Biochemistry, and Behavior. 172818. PMID 31682894 DOI: 10.1016/J.Pbb.2019.172818  0.731
2019 Bornebusch AB, Fink-Jensen A, Wörtwein G, Seeley RJ, Thomsen M. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs. Eneuro. 6. PMID 31058214 DOI: 10.1523/ENEURO.0443-18.2019  0.641
2019 Brunchmann A, Thomsen M, Fink-Jensen A. The effect of glucagon-like PEPTIDE-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review. Physiology & Behavior. PMID 30946836 DOI: 10.1016/J.Physbeh.2019.03.029  0.715
2019 Townsend EA, Negus SS, Caine SB, Thomsen M, Banks ML. Sex differences in opioid reinforcement under a fentanyl vs. foodchoice procedure in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30818323 DOI: 10.1038/S41386-019-0356-1  0.57
2018 Thomsen M, Holst JJ, Molander A, Linnet K, Ptito M, Fink-Jensen A. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Psychopharmacology. PMID 30382353 DOI: 10.1007/S00213-018-5089-Z  0.646
2017 Stoll K, Hart R, Lindsley CW, Thomsen M. Effects of muscarinic M1 and M4 acetylcholine receptor stimulation on extinction and reinstatement of cocaine seeking in male mice, independent of extinction learning. Psychopharmacology. PMID 29250738 DOI: 10.1007/S00213-017-4797-0  0.602
2017 Dencker D, Molander A, Thomsen M, Schlumberger C, Wortwein G, Weikop P, Benveniste H, Volkow ND, Fink-Jensen A. Ketogenic Diet suppresses Alcohol Withdrawal Syndrome in Rats. Alcoholism, Clinical and Experimental Research. PMID 29160944 DOI: 10.1111/Acer.13560  0.746
2017 Thomsen M, Sørensen G, Dencker D. Physiological roles of CNS muscarinic receptors gained from knockout mice. Neuropharmacology. PMID 28911965 DOI: 10.1016/J.Neuropharm.2017.09.011  0.494
2017 Thomsen M, Dencker D, Wortwein G, Weikop P, Egecioglu E, Jerlhag E, Fink-Jensen A, Molander A. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice. Pharmacology, Biochemistry, and Behavior. PMID 28778739 DOI: 10.1016/J.Pbb.2017.07.014  0.771
2017 Dall C, Weikop P, Dencker D, Molander AC, Wörtwein G, Conn PJ, Fink-Jensen A, Thomsen M. Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine. Drug and Alcohol Dependence. 176: 154-161. PMID 28544993 DOI: 10.1016/J.Drugalcdep.2017.03.014  0.805
2017 Thomsen M, Barrett AC, Butler P, Negus SS, Caine SB. Effects of acute and chronic treatments with D2 and D3 receptor ligands on cocaine vs. food choice in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 28473458 DOI: 10.1124/jpet.117.241141  0.631
2017 Joseph L, Thomsen M. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice. Behavioural Brain Research. PMID 28442355 DOI: 10.1016/J.Bbr.2017.04.023  0.612
2016 Sørensen G, Caine SB, Thomsen M. Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice. Alcoholism, Clinical and Experimental Research. 40: 2247-2252. PMID 27579999 DOI: 10.1111/Acer.13199  0.495
2016 Thomsen M, Caine SB. Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice. European Journal of Pharmacology. 776: 71-80. PMID 26874213 DOI: 10.1016/J.Ejphar.2016.02.034  0.603
2014 Thomsen M. Locomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis. Behavioural Pharmacology. 25: 259-66. PMID 24769455 DOI: 10.1097/Fbp.0000000000000043  0.534
2014 Caine SB, Collins GT, Thomsen M, Wright C, Lanier RK, Mello NK. Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents. Experimental and Clinical Psychopharmacology. 22: 9-22. PMID 24490708 DOI: 10.1037/A0035749  0.63
2014 Thomsen M, Fulton BS, Caine SB. Acute and chronic effects of the M1/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats. Psychopharmacology. 231: 469-79. PMID 23995301 DOI: 10.1007/S00213-013-3256-9  0.576
2013 Thomsen M, Barrett AC, Negus SS, Caine SB. Cocaine versus food choice procedure in rats: environmental manipulations and effects of amphetamine. Journal of the Experimental Analysis of Behavior. 99: 211-33. PMID 23319458 DOI: 10.1002/Jeab.15  0.647
2013 Thomsen M, Fulton BS, Caine SB. C.23 - Acute And Chronic Effects Of The M1/M4-Preferring Muscarinic Agonist Xanomeline On Cocaine Vs. Food Choice In Rats Behavioural Pharmacology. 24. DOI: 10.1097/01.Fbp.0000434807.27076.B1  0.524
2012 Caine SB, Thomsen M, Barrett AC, Collins GT, Grundt P, Newman AH, Butler P, Xu M. Cocaine self-administration in dopamine D₃ receptor knockout mice. Experimental and Clinical Psychopharmacology. 20: 352-63. PMID 22867038 DOI: 10.1037/A0029135  0.74
2012 Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease. Acs Chemical Neuroscience. 3: 80-89. PMID 22389751 DOI: 10.1021/Cn200110Q  0.808
2012 Thomsen M, Lindsley CW, Conn PJ, Wessell JE, Fulton BS, Wess J, Caine SB. Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice Psychopharmacology. 220: 673-685. PMID 21964721 DOI: 10.1007/S00213-011-2516-9  0.7
2012 Dencker D, Thomsen M, Wörtwein G, Weikop P, Cui Y, Jeon J, Wess J, Fink-Jensen A. Muscarinic acetylcholine receptor subtypes as potential drug targets for the treatment of schizophrenia, drug abuse, and Parkinson's disease Acs Chemical Neuroscience. 3: 80-89. DOI: 10.1021/cn200110q  0.553
2011 Thomsen M, Ralph RJ, Caine SB. Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains. Experimental and Clinical Psychopharmacology. 19: 342-60. PMID 21843011 DOI: 10.1037/A0024053  0.441
2011 Thomsen M, Caine SB. Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Experimental and Clinical Psychopharmacology. 19: 321-41. PMID 21843010 DOI: 10.1037/A0024798  0.524
2011 Thomsen M, Caine SB. False positive in the intravenous drug self-administration test in C57BL/6J mice. Behavioural Pharmacology. 22: 239-47. PMID 21522054 DOI: 10.1097/Fbp.0B013E328345F8F2  0.511
2011 Dencker D, Wörtwein G, Weikop P, Jeon J, Thomsen M, Sager TN, Mørk A, Woldbye DPD, Wess J, Fink-Jensen A. Involvement of a subpopulation of neuronal M 4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M 1/M 4 preferring muscarinic receptor agonist xanomeline Journal of Neuroscience. 31: 5905-5908. PMID 21508215 DOI: 10.1523/Jneurosci.0370-11.2011  0.799
2011 Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DPD, Wortwein G, Fink-Jensen A. Increased cocaine self-administration in M 4 muscarinic acetylcholine receptor knockout mice Psychopharmacology. 216: 367-378. PMID 21373792 DOI: 10.1007/S00213-011-2225-4  0.824
2011 Lin Z, Canales JJ, Björgvinsson T, Thomsen M, Qu H, Liu QR, Torres GE, Caine SB. Monoamine transporters: vulnerable and vital doorkeepers. Progress in Molecular Biology and Translational Science. 98: 1-46. PMID 21199769 DOI: 10.1016/B978-0-12-385506-0.00001-6  0.263
2010 Thomsen M, Wess J, Fulton BS, Fink-Jensen A, Caine SB. Modulation of prepulse inhibition through both M1 and M 4 muscarinic receptors in mice Psychopharmacology. 208: 401-416. PMID 20013114 DOI: 10.1007/S00213-009-1740-Z  0.726
2010 Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, Fink-Jensen A, Caine SB. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation Journal of Pharmacology and Experimental Therapeutics. 332: 959-969. PMID 19996296 DOI: 10.1124/Jpet.109.162057  0.785
2009 Thomsen M, Han DD, Gu HH, Caine SB. Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 331: 204-11. PMID 19602552 DOI: 10.1124/Jpet.109.156265  0.557
2009 Thomsen M, Hall FS, Uhl GR, Caine SB. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1087-92. PMID 19176817 DOI: 10.1523/Jneurosci.4037-08.2009  0.57
2008 Thomsen M, Fink-Jensen A, Woldbye DP, Wörtwein G, Sager TN, Holm R, Pepe LM, Caine SB. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology. 201: 43-53. PMID 18612628 DOI: 10.1007/S00213-008-1245-1  0.765
2008 Zuo CS, Seoane PR, Thomsen M, Gillis T, Meloni E, Harnish PP, Renshaw PF. EVP-ABD-enhanced MRI to evaluate diffuse liver disease in a rat model Journal of Magnetic Resonance Imaging. 27: 1317-1321. PMID 18504762 DOI: 10.1002/jmri.21385  0.209
2008 Sørensen G, Sager TN, Petersen JH, Brennum LT, Thøgersen P, Hee Bengtsen C, Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology. 199: 37-46. PMID 18481046 DOI: 10.1007/S00213-008-1069-Z  0.792
2007 Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, Koob GF, Tonegawa S, Zhang J, Xu M. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13140-50. PMID 18045908 DOI: 10.1523/Jneurosci.2284-07.2007  0.67
2007 Thomsen M, Wörtwein G, Olesen MV, Begtrup M, Havez S, Bolwig TG, Woldbye DP. Involvement of Y(5) receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test. Brain Research. 1155: 49-55. PMID 17498669 DOI: 10.1016/J.Brainres.2007.04.021  0.673
2007 Thomsen M, Wörtwein G, Fink-Jensen A, Woldbye DP, Wess J, Caine SB. Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology. 192: 97-110. PMID 17310388 DOI: 10.1007/S00213-006-0682-Y  0.8
2007 Thomsen M, Caine SB. Intravenous drug self-administration in mice: practical considerations. Behavior Genetics. 37: 101-18. PMID 17226102 DOI: 10.1007/S10519-006-9097-0  0.462
2006 Thomsen M, Caine SB. Cocaine self-administration under fixed and progressive ratio schedules of reinforcement: comparison of C57BL/6J, 129X1/SvJ, and 129S6/SvEvTac inbred mice. Psychopharmacology. 184: 145-54. PMID 16369835 DOI: 10.1007/S00213-005-0207-0  0.515
2005 Thomsen M, Caine SB. Chronic intravenous drug self-administration in rats and mice Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. PMID 18428629 DOI: 10.1002/0471142301.Ns0920S32  0.447
2005 Thomsen M, Woldbye DP, Wörtwein G, Fink-Jensen A, Wess J, Caine SB. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8141-9. PMID 16148222 DOI: 10.1523/Jneurosci.2077-05.2005  0.82
2003 Fink-Jensen A, Fedorova I, Wörtwein G, Woldbye DP, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. Journal of Neuroscience Research. 74: 91-6. PMID 13130510 DOI: 10.1002/Jnr.10728  0.828
Low-probability matches (unlikely to be authored by this person)
2023 Kyriakidou M, Caballero-Puntiverio M, Andreasen JT, Thomsen M. Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 127: 110841. PMID 37586638 DOI: 10.1016/j.pnpbp.2023.110841  0.134
Hide low-probability matches.